Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712671 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Proteomics R' returned 5406 results - Page 1 of 271

 FEATURED RESULTS
Cell Therapy - Technologies, Markets and Companies

Proteomics - Technologies, Markets and Companies

Gene Therapy - Technologies, Markets and Companies

Personalized Medicine - Scientific and Commercial Aspects

Cytogenetics - Technologies, Markets and Companies


  Sort by   
  Sorted by Rank Top-Bottom

Post Genome Project Era Proteomics R&D Competition  
Fuji-Keizai USA, Inc., Jan 2003, Pages: 159
the return on their R&D dollars by raising R&D productivity. Proteomics offers a clearer path toward this than genomics for several reasons. First, the same proteomics platforms can be used to test multiple


Proteomics - Technologies, Markets and Companies  
Jain PharmaBiotech, Feb 2012, Pages: 607
10-1: Types of companies involved in proteomics collaborations Figure 10-2: Types of collaborations: R & D, licensing or marketing Figure 10-3: Proteomics collaborations according to application


Proteomics - Global Strategic Business Report  
Global Industry Analysts, Inc., Sep 2010, Pages: 694
This report analyzes the worldwide markets for Proteomics in US$ Million by the following product segments: Expression Proteomics, Functional Proteomics, and Structural Proteomics.The report


Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine  
JZMed Inc., Jan 2011, Pages: 282
history) in genomics and proteomics, molecular biomarker, diagnostics and medical device. - The report also conducted in-depth analyses with regards to the overall global R&D climate for genomics


Know the Other "Omics": Exploring Drug and Diagnostics Development through Proteomics  
Decision Resources, Inc., March 2009, Pages: 25
Technologies for Cancer Initiative - Pharmaceutical and Diagnostics Company Sponsors of the Human Plasma Proteome Project List of Figures - FDA Approval of NMEs Compared with R&D Spending, 2000


Biomarkers: Discovery Techniques and Applications – A Global Market Overview  
Industry Experts, Sep 2010, Pages: 230
in proteomics and biomarker discovery as against a broad exploration of the entire proteome. As a result, focus on sample preparation has gained in importance, with researchers devoting more time in simplifying


Life Sciences Research Tools Market  
DeciBio, Feb 2011, Pages: 55
PCR, digital PCR, CE sequencing, next generation sequencing (NGS) / third generation sequencing (3GS), microarrays, molecular biology tools) 2) pure proteomics technologies (protein isolation and analysis, ELISA


World Blood Banking Market Key Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants  
Venture Planning Group, Dec 2011, Pages: 50
in R&D, collaborative arrangements, and business strategies. Companies covered include: - Abbott - Beckman Coulter - Biokit - BioMerieux - Bio-Rad - Bioscot - Biotest - Chiron - Diagast - Diamed - Dia


Biomarkers - Technologies, Markets and Companies  
Jain PharmaBiotech, Feb 2012, Pages: 864
as development has increased remarkably since the beginning of the 21st century. This report describes different types of biomarkers and their discovery using various “-omics” technologies such as proteomics


Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review  
GlobalData, Sep 2011, Pages: 38
Lab System. The company operates through three geographic segments, namely, UK, Germany and US. The company's subsidiaries include Proteome Sciences R&D Verwaltungs GmbH, Proteome Sciences R&D GmbH & Co. KG


The Future of Personalized Medicine: The Impact of Proteomics on Drug Discovery And Clinical Trial Design  
Business Insights, Oct 2004
to the more cost-effective development of niche personalized products of the future. Proteomics promises lower R&D costs and the opportunities of new revenue streams through the identification of new drug


Leading Blood Banking Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants  
Venture Planning Group, April 2010, Pages: 50
in R&D, collaborative arrangements, and business strategies.Contains 50 pages - Abbott - Beckman Coulter - Biokit - BioMerieux - Bio-Rad - Bioscot - Biotest - Chiron - Diagast - Diamed - Dia


Advanced Proteome Therapeutics Corporation (APC) - Financial and Strategic SWOT Analysis Review  
GlobalData, June 2011, Pages: 30
Proteome Therapeutics Corporation - Threats Threat - Tightening of FDA’s Regulatory Oversight Threat - Industry Consolidation Threat - Uncertain R&D Outcomes Advanced Proteome Therapeutics


Global Bioinformatics Market Outlook  
RNCOS E-Services Private Limited, March 2011, Pages: 70
. A host of developments are taking place in genomics and molecular research that are likely to boost the bioinformatics industry. Moreover, significant advances in the field of proteomics and related


Biomarkers, Tests and Trends for Drug R&D  
Takeda Pacific, Feb 2010, Pages: 144
, applications, M&As, alliances, tools & technologies, products and R&D services. This report provides a detailed outlook of the market for biomarkers and related genomic, proteomic, or other tests used in drug R


Technology Developments in Functional Proteomics (Technical Insights)  
Frost & Sullivan, Sep 2006
This Frost & Sullivan research service titled Functional Proteomics provides an overview of enabling technologies in functional proteomics, along with a complete analysis of key market drivers


Drug Discovery Technologies - A Global Update of Market Trends & Opportunities  
Bizacumen Inc., Nov 2009, Pages: 488
pharmaceutical R&D. These technologies include bioanalytical instruments, genomics, pharmacogenomics, combinatorial chemistry, biochip, proteomics, bioinformatics and high throughput screening (HTS). Use


Biomarkers of Kidney Disease  
Elsevier Science and Technology, Oct 2010, Pages: 454
metabolomics and proteomics is covered in the book. This comprehensive book details the latest advances made in the field of biomarker research and development in kidney diseases. The book is an ideal companion


The 2011 Global Pharmaceutical Market Dynamics and Trends  
Venture Planning Group, Sep 2011, Pages: 25
impact on the pharmaceutical industry during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well


The 2011 Global Animal Health Market Dynamics and Trends  
Venture Planning Group, Sep 2011, Pages: 12
, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics and other technologies.Analysis of key market segments.Review of major geographic


Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds